S. Abdel-Rahman
About
S. Abdel-Rahman is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, S. Abdel-Rahman has authored 26 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 8 papers in Biomedical Engineering and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S. Abdel-Rahman's work include Sarcoma Diagnosis and Treatment (16 papers), Ultrasound and Hyperthermia Applications (8 papers) and Virus-based gene therapy research (7 papers). S. Abdel-Rahman is often cited by papers focused on Sarcoma Diagnosis and Treatment (16 papers), Ultrasound and Hyperthermia Applications (8 papers) and Virus-based gene therapy research (7 papers). S. Abdel-Rahman collaborates with scholars based in Germany, Switzerland and Netherlands. S. Abdel-Rahman's co-authors include Rolf D. Issels, Wolfgang Hiddemann, Martin Falk, Clemens‐Martin Wendtner, H. Sauer, Manfred Schmidt, Johannes Crezee, Ü. Aydemir, Volker Kurze and Gerard C. van Rhoon and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.
In The Last Decade
S. Abdel-Rahman
25 papers receiving 369 citations
Peers
S. Abdel-Rahman
Maria Stanczak United States
D.S. Kapp United States
D. González Netherlands
Xiaozhou Fan China
Shiken Jo Japan
Chi Yin Tso China
S. Oldenborg Netherlands
Sunil Unnikrishnan United States
A Masters United Kingdom
M Kakehi Japan
Citations per year, relative to S. Abdel-Rahman S. Abdel-Rahman (= 1×)
peers
Maria Stanczak
Countries citing papers authored by S. Abdel-Rahman
Since
Specialization
Citations
This map shows the geographic impact of S. Abdel-Rahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Abdel-Rahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Abdel-Rahman more than expected).
Fields of papers citing papers by S. Abdel-Rahman
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by S. Abdel-Rahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Abdel-Rahman. The network helps show where S. Abdel-Rahman may publish in the future.
Co-authorship network of co-authors of S. Abdel-Rahman
This figure shows the co-authorship network connecting the top 25 collaborators of S. Abdel-Rahman. A scholar is included among the top collaborators of S. Abdel-Rahman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Abdel-Rahman. S. Abdel-Rahman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Abdel-Rahman, S., et al.. (2025). Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions. Pharmaceuticals. 18(2). 257–257.
2.
Jurinović, Vindi, S. Abdel-Rahman, Markus Albertsmeier, et al.. (2025). Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score‐Matched Analysis. Cancer Medicine. 14(4). e70655–e70655.
3.
Abdel-Rahman, S., et al.. (2024). USING ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING APPROACHES TO ENHANCE CANCER THERAPY AND DRUG DISCOVERY. Journal of Ayub Medical College Abbottabad. 36(1). 183–189.
4.
Kok, H. Petra, Jacoba van der Zee, A. Bakker, et al.. (2021). Treatment planning facilitates clinical decision making for hyperthermia treatments. International Journal of Hyperthermia. 38(1). 532–551.
5.
Manz, Kirsi, et al.. (2019). Regional deep hyperthermia: quantitative evaluation of predicted and direct measured temperature distributions in patients with high-risk extremity soft-tissue sarcoma. International Journal of Hyperthermia. 36(1). 169–184.
6.
Kampmann, Eric, Gesa Schuebbe, S. Abdel-Rahman, et al.. (2012). Comparison of Two Chemotherapy Regimens (AI vs. EIA) Combined with Regional Hyperthermia (RHT) in High-Risk Soft-Tissue Sarcoma (HR-STS). Annals of Oncology. 23. ix487–ix487.
7.
Bruggmoser, G., Richard Canters, Johannes Crezee, et al.. (2012). Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia. Strahlentherapie und Onkologie. 188(S2). 198–211.
8.
Abdel-Rahman, S., Lars H. Lindner, Christoph Salat, et al.. (2011). Regional hyperthermia (RHT) as an innovative treatment component: RHT combined with gemcitabine (G) and cisplatin (CIS) in G-pretreated advanced pancreatic cancer (APC).. Journal of Clinical Oncology. 29(15_suppl). e14524–e14524.
9.
Schlemmer, M., Clemens-M. Wendtner, Lars H. Lindner, et al.. (2010). Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS). International Journal of Hyperthermia. 26(2). 127–135.
10.
Nickenig, Christina, et al.. (2009). Ifosfamide, carboplatin, and etoposide (ICE) in combination with regional hyperthermia (RHT) in chemotherapy-pretreated nonresponders with locally advanced high-risk soft tissue sarcoma (HR-STS). Journal of Clinical Oncology. 27(15_suppl). 10581–10581.
11.
Tschoep, Katharina, Stefan Boeck, Frédérique Berger, et al.. (2008). Regional hyperthermia (RHT) combined with gemcitabine (GEM) + cisplatin (CIS) in patients with GEM-refractory advanced pancreatic cancer: Results of the ESHO phase II trial. Journal of Clinical Oncology. 26(15_suppl). 4635–4635.
12.
Fiegl, Michael, et al.. (2004). Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults. International Journal of Hyperthermia. 20(6). 661–670.
13.
Schlemmer, M., Peter Hohenberger, Peter Wust, et al.. (2004). First interim report on the randomized EORTC 62961/ESHO-RHT 95 Intergroup Study (phase III) combined with regional hyperthermia (RHT) versus chemotherapy alone in the treatment of high-risk soft tissue sarcomas (HR-STS) in adults. Journal of Clinical Oncology. 22(14_suppl). 9015–9015.
14.
Hohenberger, Peter, Peter Wust, S. Abdel-Rahman, et al.. (2004). First interim report on the randomized EORTC 62961/ESHO-RHT 95 Intergroup Study (phase III) combined with regional hyperthermia (RHT) versus chemotherapy alone in the treatment of high-risk soft tissue sarcomas (HR-STS) in adults. Journal of Clinical Oncology. 22(14_suppl). 9015–9015.
15.
Schaffer, Moshe, S. Abdel-Rahman, P.M. Schaffer, et al.. (2003). Feasibility and Morbidity of Combined Hyperthermia and Radiochemotherapy in Recurrent Rectal Cancer – Preliminary Results. Oncology Research and Treatment. 26(2). 120–124.
16.
Issels, Rolf D., S. Abdel-Rahman, Clemens‐Martin Wendtner, et al.. (2001). Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults. European Journal of Cancer. 37(13). 1599–1608.
17.
Wendtner, Clemens‐Martin, S. Abdel-Rahman, Jens Baumert, et al.. (2001). Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults. European Journal of Cancer. 37(13). 1609–1616.
18.
Peller, Michael, Andrea Baur, Peter Turner, et al.. (1999). MRT-gesteuerte regionale Tiefenhyperthermie. Der Radiologe. 39(9). 756–763.
19.
Issels, Rolf D., et al.. (1999). Initial response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) in high-risk soft tissue sarcomas (HR-STS) of adults and its correlation to survival parameters. European Journal of Cancer. 35. S266–S266.
20.
Issels, Rolf D., Dominick Bossé, S. Abdel-Rahman, et al.. (1993). Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.. PubMed. 31 Suppl 2. S233–7.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Maria Stanczak Breakdown of academic impact, for papers by D.S. Kapp Breakdown of academic impact, for papers by D. González Breakdown of academic impact, for papers by Xiaozhou Fan Breakdown of academic impact, for papers by Shiken Jo Breakdown of academic impact, for papers by Chi Yin Tso Breakdown of academic impact, for papers by S. Oldenborg Breakdown of academic impact, for papers by Sunil Unnikrishnan Breakdown of academic impact, for papers by A Masters Breakdown of academic impact, for papers by M Kakehi